Citation

65 FR 62364

Canonical document for this Federal Register citation.

"Guidance for Industry: Supplemental Guidance on Testing for Replication Competent Retrovirus in Retroviral Vector Based Gene Therapy Products and During Follow-up of Patients in Clinical Trials Using Retroviral Vectors;" Availability Wednesday, October 18, 2000 65 FR 62364